Re: Farmas USA
Re: Farmas USA
ARNA: Os pongo tres artículos de hoy en Seeking Alpha:
1) Escrito por un tal Mathew Smith, que según SA es el nº1 en "Commodities" y "Market Outlook" y el nº4 en "Basic Materials"
De ARNA dice lo siguiente:
"We have gotten many emails and a few comments on Arena Pharmaceuticals (ARNA) and our view that the shares are worth at least $10/share with a price target of between $15-20/share. We try to keep our emotions on the sideline when investing, and that is what allowed us to remain bullish as shares headed south. With the latest run Arena is back up to $9.99 and rose $0.63 (6.71%) on volume of 17.9 million shares yesterday. We continue to believe that readers should hold shares as this will be one of the major players in the weight loss drug market and if we are correct in our thinking then the company will become a cash generating machine."
http://seekingalpha.com/article/931821-today-s-market-news-to-trade-on-5-stocks-moving-on-news?source=intbrokers_regular
2) A Conservative Valuation For Belviq In The EU:
http://seekingalpha.com/article/931541-a-conservative-valuation-for-belviq-in-the-eu?source=intbrokers_regular
3) 5 Big Time Biotech Movers On Wednesday (habla también de GALE y PPHM, aparte de otras como ITMN y ONCS)
http://seekingalpha.com/article/931391-5-big-time-biotech-movers-on-wednesday?source=intbrokers_regular
Re: Farmas USA
Re: Farmas USA
Re: Farmas USA
Re: Farmas USA
QCOR
A esta no paran de meterle paquetes los abogados, pero va hacia arriba sin piedad.